左心室辅助装置植入后肝功能障碍的风险
该研究回顾性分析了2007至2017年单中心连续359例连续流左心室辅助装置植入患者,评估围术期风险标志物与INT-LD的关系。发现右心室每搏做功指数低、右心导管后6小时右房压高、术前总胆红素高、体外循环时间长及超滤量大与INT-LD独立相关,且INT-LD与1年生存率降低相关。
要点
- 右心室每搏做功指数<460 mm Hg·mL/m2与INT-LD风险升高相关(OR 4.6)。
- 体外循环时间>137分钟及超滤量>2.95 L均与INT-LD风险升高相关。
- INT-LD与未校正1年生存率降低相关(P<.001)。
核心结论
- 右心室每搏做功指数、右心导管后6小时右房压、体外循环时间及超滤量对INT-LD风险的关联强于总胆红素。
- 优化右心室血流动力学、缩短体外循环时间及减少超滤可能降低肝功能障碍风险,但需前瞻性验证。
研究设计与样本
- 单中心回顾性队列研究,纳入2007至2017年连续359例连续流左心室辅助装置植入患者。
- 采用单变量建模并经错误发现率校正,对与INT-LD最显著相关的变量进行逻辑回归并确定最佳截断值。
- 采用Kaplan-Meier分析评估1年生存率。
主要发现
- 右心导管时右心室每搏做功指数较低、右心导管后6小时右房压较高、术前总胆红素较高、体外循环时间较长及术中超滤量较大与INT-LD发生最强烈相关(校正P<.01)。
- 右心室每搏做功指数<460 mm Hg·mL/m2(OR 4.6;95%CI 2.3-9.4)、6小时右房压≥14 mm Hg(OR 4.3;95%CI 2.1-8.8)、体外循环时间>137分钟(OR 3.3;95%CI 1.8-6.2;P<.01)、超滤量>2.95 L(OR 3.7;95%CI 2-6.8)及总胆红素>1.4 mg/dL(OR 2.7;95%CI 1.4-5)均与INT-LD风险强烈相关。
- INT-LD与未校正1年生存率降低相关(P<.001)。
关键数值与推荐
- INT-LD定义采用Interagency Registry for Mechanically Assisted Circulatory Support标准。
- 右心室每搏做功指数<460 mm Hg·mL/m2:OR 4.6(95%CI 2.3-9.4)。
- 右心导管后6小时右房压≥14 mm Hg:OR 4.3(95%CI 2.1-8.8)。
- 体外循环时间>137分钟:OR 3.3(95%CI 1.8-6.2;P<.01)。
- 超滤量>2.95 L:OR 3.7(95%CI 2-6.8);总胆红素>1.4 mg/dL:OR 2.7(95%CI 1.4-5)。
临床怎么用
- 对左心室辅助装置植入患者,应关注右心室每搏做功指数、右心导管后6小时右房压、体外循环时间及超滤量等围术期指标。
- 优化右心室血流动力学、缩短体外循环时间及减少超滤可能有助于降低INT-LD风险。
局限性
- 单中心回顾性研究,结果需前瞻性验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Incident liver dysfunction after left ventricular assist device implantation has been previously associated with adverse outcomes, yet data on perioperative risk markers are sparse. METHODS: We retrospectively reviewed consecutive patients undergoing continuous-flow left ventricular assist device implant between 2007 and 2017 at a single institution. Perioperative variables were evaluated by univariate modeling and adjusted for false discovery rate. Variables most significantly associated with incident Interagency Registry for Mechanically Assisted Circulatory Support-defined liver dysfunction (INT-LD) were evaluated using logistic regression and optimal cutpoints were defined. One-year survival was evaluated using Kaplan-Meier analysis. RESULTS: We included 359 patients (79% male; mean age 59 ± 13 years; 46% ischemic; 64% destination therapy). Lower right ventricular stroke work index at the time of right heart catheterization, higher right atrial pressure 6 hours after right heart catheterization, higher preoperative total bilirubin, longer cardiopulmonary bypass time, and greater volume of intraoperative ultrafiltration were most strongly associated with incident INT-LD (adjusted P < .01 for each). Initial right ventricular stroke work index less than 460 mm Hg∗mL/m2 (odds ratio [OR] 4.6; 95% confidence interval [CI], 2.3 to 9.4), 6-hour right heart catheterization 14 mm Hg or greater (OR 4.3; 95% CI, 2.1 to 8.8), cardiopulmonary bypass time longer than 137 minutes (OR 3.3; 95% CI, 1.8 to 6.2; P < .01 for all), ultrafiltration more than 2.95 L (OR 3.7; 95% CI, 2 to 6.8), and total bilirubin greater than 1.4 mg/dL (OR 2.7; 95% CI, 1.4 to 5) were each strongly associated with risk of INT-LD, which was associated with decreased unadjusted 1-year survival (P < .001). CONCLUSIONS: Right ventricular stroke work index, right heart catheterization, cardiopulmonary bypass time, and ultrafiltration were each more strongly associated with elevated risk of INT-LD after left ventricular assist device implant than total bilirubin. Therefore, optimization of right ventricular hemodynamics and minimizing cardiopulmonary bypass time and ultrafiltration could potentially reduce the risk of liver dysfunction, but these observations require prospective validation.
引用
- Rosenbaum AN, Ternus BW, Pahwa S, et al. Risk of Liver Dysfunction After Left Ventricular Assist Device Implantation. Ann Thorac Surg. 2020. PMID: 33058819. doi:10.1016/j.athoracsur.2020.08.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。